510(k) Report

510(k) · Cleared

Cleared

BSM- Bone Substitute Material

K983009510(k) TraditionalCleared Nov 25, 199889-day reviewClass II21 CFR 882.5300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Etex Corp. · GXP Methyl Methacrylate For Cranioplasty

Cleared on Nov 25, 1998 as substantially equivalent to K953339 (Osteogenics, Inc., 1996) after an 89-day review. Its family tree reaches back 2 generations to 1987. 4 later devices descend from it.

Decided
Nov 25, 1998
Review
89 days
Class
Class II
Product code
GXP
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K873689 (1987). 4 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2009: 1 descendant cleared2003: 1 descendant cleared2010: 2 descendants clearedK873689 · Cranioplastic, Acrylic Cranioplasty Material · Dentsply Intl. · 1987K953339 · Bonesource Hydroxyapatite Cement (Hac) · Osteogenics, Inc. · 19961990200020102020
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 2 descendants K953339 · Bonesource Hydroxyapatite Cement (Hac) · Osteogenics, Inc. · 1996K873689 · Cranioplastic, Acrylic Cranioplasty Material · Dentsply Intl. · 19870
  1. Root · 2 generations backK873689 Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl. · 1987
  2. 1 generation backK953339 Bonesource Hydroxyapatite Cement (Hac)Osteogenics, Inc. · 1996
  3. This deviceK983009 BSM- Bone Substitute MaterialEtex Corp. · 1998
  4. Descendant · cites it directly · 3 of its ownK032307 Cap Bone Substitute MaterialEtex Corp. · 2003
  5. Descendant · cites it directly · 2 of its ownK091729 Alpha-BSM, Beta-BSM, Gamma-BSM, EquivaboneEtex Corp. · 2009
  6. Descendant · 2 generations on · 0 of its ownK100883 CarrigenEtex Corp. · 2010
  7. Descendant · 2 generations on · 0 of its ownK102812 Gamma-BSM; Beta-BSM; EquivaboneEtex Corporation · 2010

Most influential descendants

Showing 4 of 4 · See all
  • K032307Cap Bone Substitute MaterialEtex Corp. · 2003 · cites it directly3descendants
  • K091729Alpha-BSM, Beta-BSM, Gamma-BSM, EquivaboneEtex Corp. · 2009 · cites it directly2descendants
  • K100883CarrigenEtex Corp. · 2010 · 2 generations on0descendants
  • K102812Gamma-BSM; Beta-BSM; EquivaboneEtex Corporation · 2010 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K873689Cranioplastic, Acrylic Cranioplasty MaterialDentsply Intl.1987—
−1K953339Bonesource Hydroxyapatite Cement (Hac)Osteogenics, Inc.1996—
0 (this device)K983009BSM- Bone Substitute MaterialEtex Corp.1998—
+1K032307Cap Bone Substitute MaterialEtex Corp.2003—
+1K091729Alpha-BSM, Beta-BSM, Gamma-BSM, EquivaboneEtex Corp.2009—
+2K100883CarrigenEtex Corp.2010—
+2K102812Gamma-BSM; Beta-BSM; EquivaboneEtex Corporation2010—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200910
201020
FIG. 1 — Lineage of K983009, 1987–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXP device

  1. #1 K241027 Permatage Settable Bone Puttyscore 16.5 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K953339Bonesource Hydroxyapatite Cement (Hac)
Summary page 1
…titute Matenal 2.3 Classification Name and Code: Methyl Methacrylate for Cranioplasty, Code GXP 2.4 Predicate Device: BoneSource™ Hydroxyapatite Cement S10(k) No.: K953339, Osteogenics, Inc. 2.5 Description of Device ETEX a-BSM™ Bone Substitute Material for Cranioplasty is a self-setting, syntheti…
Osteogenics, Inc.1996—

Also cleared against K953339: 3 other devices →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K032307Cap Bone Substitute MaterialEtex Corp.20033
K091729Alpha-BSM, Beta-BSM, Gamma-BSM, EquivaboneEtex Corp.20092

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 8.7 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K032307 (Etex Corp., 2003) has gone furthest, with 3 descendants of its own.
  • 3 other devices also cite its predicate K953339.

How does its category compare?

All GXP devices

GXP Methyl Methacrylate For Cranioplasty: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GXP

4so far in 2026, the most since 2007

2007: 32009: 12010: 12015: 12017: 12019: 12023: 22024: 22026 (partial year): 4
2007high 4 (2026) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXP

87in 2007

2007: 87 days median2026 (partial year): 85 days median
2007high 87 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXP

2in 2019

2009: 12011: 12012: 12019: 2
2007high 2 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXP

1in 2025

2007: 82008: 102009: 222010: 592011: 312012: 282013: 182014: 192015: 132016: 172017: 162018: 92019: 92020: 312021: 142022: 32023: 22024: 102025: 1
2007high 59 (2010) · low 1 (2025)2025

MAUDE reports naming product code GXP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200738708
20080—010
20091—122
20101—059
20110—131
20120—128
20130—018
20140—019
20151—013
20160—017
20171—016
20180—09
20191—29
20200—031
20210—014
20220—03
20232—02
20242—010
20250—01
20264850—

What is it indicated for?

a-BSM™ Bone Substitute Material is a synthetic calcium phosphate hydroxyapatitic material intended to be implanted for use in the filling, repair, reconstruction and augmentation of burr holes, contiguous craniotomy cuts, and other defects in craniofacial bones including fronto-orbital, malar and mental areas with a surface area no larger than 25cm².

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983009: BSM- Bone Substitute Material.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K983009

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026